MedPath

Reynolds, Helen

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Drug Interactions Between Dolutegravir and Escalating Doses of Rifampicin

Phase 4
Completed
Conditions
Hiv
Tuberculosis
Interventions
First Posted Date
2019-11-18
Last Posted Date
2024-08-13
Lead Sponsor
Helen Reynolds
Target Recruit Count
36
Registration Number
NCT04166474
Locations
๐Ÿ‡ฟ๐Ÿ‡ฆ

Desmond Tutu Health Foundation, Cape Town, South Africa

๐Ÿ‡บ๐Ÿ‡ฌ

Infectious Diseases Institute, Kampala, Uganda

Validation of Drug Assays in Various Biological Matrices

Recruiting
Conditions
Infection
First Posted Date
2014-11-05
Last Posted Date
2024-08-07
Lead Sponsor
Helen Reynolds
Target Recruit Count
100
Registration Number
NCT02283112
Locations
๐Ÿ‡ฌ๐Ÿ‡ง

Royal Liverpool & Broadgreen Univeristy Hospitals NHS Trust, Liverpool, United Kingdom

The Effect of Antacids and Multivitamins on Raltegravir

Phase 1
Completed
Conditions
HIV
Interventions
Drug: Maalox Plus extra
Dietary Supplement: Multivitamins
Dietary Supplement: Sodium bicarbonate
First Posted Date
2013-02-05
Last Posted Date
2016-02-25
Lead Sponsor
Helen Reynolds
Target Recruit Count
15
Registration Number
NCT01784302
Locations
๐Ÿ‡ฌ๐Ÿ‡ง

Royal Liverpool University Hospital, Liverpool, United Kingdom

The Effect of Intermittent Rifampicin on Raltegravir

Phase 1
Completed
Conditions
HIV
Tuberculosis
First Posted Date
2011-08-29
Last Posted Date
2013-10-31
Lead Sponsor
Helen Reynolds
Target Recruit Count
18
Registration Number
NCT01424826
Locations
๐Ÿ‡ฌ๐Ÿ‡ง

Royal Liverpool & Broadgreen Univeristy Hospitals NHS Trust, Liverpool, United Kingdom

ยฉ Copyright 2025. All Rights Reserved by MedPath